UR-CARE

Optimizing Patient-Reported Outcome Measurement in an Inflammatory Bowel Disease Care Pathway: Results of the PROMOTION Study

N10 Optimizing colonoscopy timing in IBD using multimodal AI integrating UR-CARE

P0212 Tracing Transmural Healing in Crohn’s Disease with MRI: correlation between MR enterography, laboratory findings and endoscopy – a retrospective single centre cohort study

Predictive Utility of the Vedolizumab Clinical Decision Support Tool in a Real-World IBD Cohort: Differential Performance in Crohn’s Disease and Ulcerative Colitis

P0048 Assessing histologic and endoscopic agreement in Crohn’s disease: a cross-sectional study

Modified-two-stage versus three-stage approach in ileoanal pouch surgery for ulcerative colitis

Anastomotic leakage after ileoanal pouch surgery: risk factors and salvage rate

One-year stoma-free survival of ileoanal pouches for UC in European centers: The MIRACLE project

First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn’ disease, but not in ulcerative colitis

P503 Differentiation of patients with IBD at increased risk of CRC using UR-CARE: A Single Centre Experience

P1026 Clinical decision support tool for vedolizumab could not predict outcome in ulcerative colitis patients – a retrospective real-life single-centre cohort study

Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres – prime time for decentralisation of inflammatory bowel disease care?